Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 311

Whales English drifts to series B-plus round

New Oriental Education and Technology has led a round likely sized at approximately $18.6m, which will support development of Whales English's online English learning offering.

Feb 1, 2021

Newlink gets $100m funding transmission

Nio Capital contributed to a late-stage round that hiked the new energy service provider's overall funding to approximately $466m.

Feb 1, 2021

Tanium taps into $150m in funding

The Salesforce Ventures and Citi Ventures-backed endpoint security software provider received the funding from Ontario Teachers’ Pension Plan Board.

Feb 1, 2021

OwnBackup stores series D funding

Salesforce Ventures has returned to back a $168m round for OwnBackup, valuing the data backup technology provider at $1.4bn.

Feb 1, 2021

Sitetracker locates $42m for series C

Invenergy, National Grid, Salesforce, Wells Fargo and Deutsche Telekom participated in the asset-tracking software developer’s latest round, which brought its total funding to $92m.

Feb 1, 2021

Ukko unveils $40m series B

Lepas by Bayer led a round for anti-allergy drug and food treatment developer Ukko that also featured Continental Grain.

Feb 1, 2021

Corporate venturing deal net: 25-29 January 2021

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jan 29, 2021

Chefclub cooks up $17m in SEB-backed round

SEB Alliance was among the participants in a round that will help the recipe publisher develop children's cooking kits along with a packaged goods offering.

Jan 29, 2021

Open8 opts for fresh funding

Japan Post Investment Corporation and Mirai Creation Fund have taken part in a $28.6m round for the video production software provider to take its total funding to almost $67m.

Jan 29, 2021

Roche extends Enthera series A

The autoimmune disease drug developer's series A round has closed at $42.4m after Roche Venture Fund added funding to a first close co-led by AbbVie Ventures.

Jan 29, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here